Overview

The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

Status:
Unknown status

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

This study is designed to evaluate the neuroprotective effect of lamotrigine in the combination of interferon beta 1a once weekly intramuscular in patients with relapsing-remitting multiple sclerosis.

Phase:

Phase 2

Details

Lead Sponsor:

Cantonal Hospital of St. Gallen

Treatments:

Anticonvulsants
Interferon beta-1a
Interferon-beta
Interferons
Lamotrigine
Neuroprotective Agents